Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress

Depression Clinical Trial

Official title: Self-Administered Meditation Intervention for Cancer Patients With Psychosocial Distress

Status Active, not recruiting

Clinical Trial Summary

This trial studies how well self-administered meditation therapy works in improving anxiety and depression in cancer patients who exhibit psychosocial distress. Meditation therapy is a mind-body approach that uses a variety of techniques, such as deep breathing, sound, or movement, that may help to decrease distress and anxiety and enhance the health and quality of life of patients with cancer.

Clinical Trial Description

PRIMARY OBJECTIVES: I. To determine the feasibility of having patients self-administer meditation recordings using a portable, computer-based program during a 2-week period. SECONDARY OBJECTIVES: I. Assess the effect of self-administered meditation on anxiety, depression and other symptoms that are part of the Edmonton Symptom Assessment Scale (ESAS) questionnaire. II. Evaluate participant satisfaction with the meditation delivery and tracking program. III. Examine the association between the frequency of practice (number of sessions a day) and choice of length of practice (5, 10, or 15 minute sessions) and anxiety, depression and other patient reported outcomes. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (MEDITATION): Patients watch a pre-recorded instructional meditation video via an iPod meditation app. Patients then complete meditation exercises using the meditation app over 5-15 minutes once daily (QD) for up to 2 weeks. Patients also complete questionnaires before and after meditation sessions and participate in an interview over 10 minutes. GROUP II (WAITLIST CONTROL): Patients receive supportive care, such as access to social workers, support groups, spiritual care, or other patient services for up to 2 weeks. Patients also complete questionnaires over 15-20 minutes and participate in an interview over 10 minutes. ;

Related Conditions & MeSH terms

• Anxiety
• Depression
• Depressive Disorder
• Malignant Neoplasm
• Neoplasms

• NCT number: NCT02988271
• Study type: Interventional
• Source: M.D. Anderson Cancer Center
• Status: Active, not recruiting
• Phase: N/A
• Start date: April 11, 2019
• Completion date: February 28, 2026